Brief: Intrasense Signs Partnership With 12 Sigma Technologies To Develop Lung Cancer Diagnosis And Analysis Solution
March 19 (Reuters) - INTRASENSE SA ALINS.PA :
* SIGNS STRATEGIC AGREEMENT WITH 12 SIGMA TECHNOLOGIES
* MULTI-YEAR AGREEMENT WITH 12 SIGMA TECHNOLOGIES TO DEVELOP
LUNG
CANCER DIAGNOSIS AND ANALYSIS SOLUTION
Source text: http://bit.ly/2u06S8R
Further company coverage: ALINS.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Intrasense SA
See all newsBrief: Guerbet Announces Results Of Reopened Public Tender Offer For Intrasense Shares
Brief: Guerbet Announces Positive Outcome Of Tender Offer For Intrasense Shares
Brief: Intrasense FY Turnover At EUR 3.8 Mln
Brief: Intrasense Partners With ICM To Optimize New Solution Dedicated To Oncology
Brief: Intrasense Opens Its Capital To The Guerbet Group